Sanofi signs US rights deal with Roche for flu treatment Tamiflu

Sanofi signs US rights deal with Roche for flu treatment Tamiflu

French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States.

FILE PHOTO: A logo of Sanofi is pictured during the company's shareholders meeting in Paris
FILE PHOTO: A logo of Sanofi is pictured during the company's shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit Tessier/File Photo

PARIS: French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States.

The deal will give Sanofi exclusive U.S. over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.

"This is a strategic and important transaction for us as we strive to continually bring innovations to the market," said Alan Main, executive vice president of Sanofi's consumer healthcare division, in a statement.

(Reporting by Sudip Kar-Gupta; Editing by Subhranshu Sahu)

Source: Reuters

Bookmark